Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 4, 2008, Pages

  Su, Xin ^a   Leon, Lisa A ^a   Wu, Charlene W ^a   Morrow, Dwight M ^a   Jaworski, Jon Paul ^a   Hieble, J Paul ^a   Lashinger, Erin S R ^a   Jin, Jian ^a   Edwards, Richard M ^a   Laping, Nicholas J ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Bladder distension; Nociception; Rhythmic contraction

Indexed keywords

3 [1 [(2,4 DICHLOROPHENYL)METHYL] 5 FLUORO 3 METHYL 1H INDOL 7 Y1] N [(4,5 DICHLORO 2 THIENYL)SULFONYL] 2 PROPENAMIDE; CM 9; DG 041; N [[5 BROMO 2 (METHYLOXY)PHENYL]SULFONYL] 3 [2 (2 NAPHTHALENYLMETHYL)PHENYL] 2 PROPENAMIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E3 RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SULPROSTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BLADDER CONTRACTION; BLADDER DISTENSION; BLADDER FUNCTION; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EMBRYO; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LIGAND BINDING; MICTURITION REFLEX; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 57049124328     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90373.2008     Document Type: Article

References (57)

1. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev 56: 581-631, 2004.
2. Angelico P, Guarneri L, Velasco C, Cova R, Leonardi A, Clarke DE, Testa R. Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes. BJU Int 97: 837-846, 2006.
3. 3 antagonists and their biological activities. Bioorg Med Chem Lett 16: 5639-5642, 2006.
4. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptors. J Biol Chem 270: 18910-18916, 1995.
5. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
6. Clarke DL, Giembycz MA, Patel HJ, Belvisi MG. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Br J Pharmacol 141: 600-609, 2004.
7. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994.
8. de Groat WC, Kawatani M, Hisamitsu T, Lowe I, Morgan C, Roppolo J, Booth AM, Nadelhaft I, Kuo D, Thor K. The role of neuropeptides in the sacral autonomic reflex pathways of the cat. J Auton Nerv Syst 7: 339-350, 1983.
9. Dray A, Metsch R. Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids. J Exp Pharmacol Ther 231: 254-260, 1984.
10. Eguchi N, Minami T, Shirafuji N, Kanaoka Y, Tanaka T, Nagata A, Yoshida N, Urade Y, Ito S, Hayaishi O. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA 96: 726-730, 1999.
11. Hall A, Billinton A, Giblin GM. EP1 antagonists for the treatment of inflammatory pain. Curr Opin Drug Discov Devel 10: 597-612, 2007.
12. Hisamitsu T, De Groat WC. The inhibitory effect of opioid peptides and morphine applied intrathecally and intracerebroventricularly on the micturition reflex in the cat. Brain Res 298: 51-65, 1984.
13. Hosoi M, Oka K, Hori T. Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats. Pain 71: 303-311, 1997.
14. Hu VY, Malley S, Dattilio A, Folsom JB, Zvara P, Vizzard MA. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide- induced cystitis in the rat. Am J Physiol Regul Integr Comp Physiol 284: R574-R585, 2003.
15. Ikeda M, Kawatani M, Maruyama T, Ishihama H. Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in rats. Biomed Res (Tokyo) 27: 49-54, 2006.
16. Ishizuka O, Mattiasson A, Andersson KE. Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? J Urol 153: 2034-2038, 1995.
17. Juteau H, Gareau Y, Labelle M, Sturino CF, Sawyer N, Tremblay N, Lamontagne S, Carriere MC, Denis D, Metters KM. Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor. Bioorg Med Chem 9: 1977-1984, 2001.
18. Kakizaki H, de Groat WC. Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation. J Urol 155: 355-360, 1996.
19. 2 causes nociceptive behaviour and mechanical allodynia: the role of prostanoid E receptors and protein kinases. Br J Pharmacol 150: 727-737, 2007.
20. Khalaf IM, Ghoneim MA, Elhilali MM. The effect of exogenous prostaglandins F2alpha and E2 and indomethacin on micturition. Br J Urol 53:21-28, 1981.
21. Kim JC, Park EY, Hong SH, Seo SI, Park YH, Hwang TK. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int J Urol 12: 875-880, 2005.
22. Kim JC, Park EY, Seo SI, Park YH, Hwang TK. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175: 1773-1776, 2006.
23. 2-induced enhancement of the bradykinin response of nociceptors. Brain Res 632: 321-324, 1993.
24. 2-induced sensitization of polymodal receptors in response to bradykinin and heat. J Neurophysiol 75: 2361-2368, 1996.
25. 1 receptor antagonist in normal rats and rats with bladder outlet obstruction. J Urol 177: 1562-1567, 2007.
26. Leon LA, Hoffman BE, Gardner SD, Laping NJ, Evans C, Lashinger ES, Su X. Effects of the 3-adrenergic receptor agonist disodium 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl] -1,3-benzodioxole-2,2-dicarboxylate (CL-316243) on bladder micturition reflex in spontaneously hypertensive rats. J Exp Pharmacol Ther 326: 1-8, 2008.
27. 1A receptor antagonist active on the lower urinary tract. J Exp Pharmacol Ther 299: 1027-1037, 2001.
28. Maggi CA, Evangelista S, Grimaldi G, Santicioli P, Giolitti A, Meli A. Evidence for the involvement of arachidonic acid metabolites in spontaneous and drug-induced contractions of rat urinary bladder. J Pharmacol Exp Ther 230: 500-513, 1984.
29. Maggi CA, Santicioli P, Meli A. Somatovesical and vesicovesical excitatory reflexes in urethane-anesthetized rats. Brain Res 380: 83-93, 1986.
30. Maggi CA, Giuliani S, Conte B, Furio M, Santicioli P, Meli P, Gragnani L, Meli A. Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferents. Eur J Pharmacol 145: 105-112, 1988.
31. Masunaga K, Yoshida M, Inadome A, Iwashita H, Miyamae K, Ueda S. Prostaglandin E2 release from isolated bladder strips in rats with spinal cord injury. Int J Urol 13: 271-276, 2006.
32. Matsumura S, Abe T, Mabuchi T, Katano T, Takagi K, Okuda-Ashitaka E, Tatsumi S, Nakai Y, Hidaka H, Suzuki M, Sasaki Y, Minami T, Ito S. Rho-kinase mediates spinal nitric oxide formation by prostaglandin E2 via EP3 subtype. Biochem Biophys Res Commun 338: 550-557, 2005.
33. Minami T, Nishihara I, Uda R, Ito S, Hyodo M, Hayaishi O. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to conscious mice. Br J Pharmacol 112: 735-740, 1994.
34. Minami T, Okuda-Ashitaka E, Mori H, Ito S, Hayaishi O. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice. J Pharmacol Exp Ther 278: 1146-1152, 1996.
35. Minami T, Nakano H, Kobayashi T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Ito S. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 133: 438-444, 2001.
36. Mizumura K, Minagawa M, Tsujii Y, Kumazawa T. Prostaglandin E2-induced sensitization of the heat response of canine visceral polymodal receptors in vitro. Neurosci Lett 161: 117-119, 1993.
37. 3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors. J Pharmacol Exp Ther 277: 1567-1571, 1996.
38. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
39. Oka T, Aou S, Hori T. Intracerebroventricular injection of prostaglandin E2 induces thermal hyperalgesia in rats: the possible involvement of EP3 receptors. Brain Res 663: 287-292, 1994.
40. Oliva P, Berrino L, De Novellis V, Palazzo E, Marabese I, Siniscalco D, Scafuro M, Mariani L, Rossi F, Maione S. Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia. Eur J Pharmacol 530: 40-47, 2006.
41. Pandita RK, Persson K, Andersson KE. Capsaicin-induced bladder overactivity and nociceptive behaviour in conscious rats: involvement of spinal nitric oxide. J Auton Nerv Syst 67: 184-191, 1997.
42. Pinna C, Zanardo R, Puglisi L. Prostaglandin-release impairment in the bladder epithelium of streptozotocin-induced diabetic rats. Eur J Pharmacol 388: 267-273, 2000.
43. Sarkar S, Hobson AR, Hughes A, Growcott J, Woolf CJ, Thompson DG, Aziz Q. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology 124: 18-25, 2003.
44. Schaible HG, Schimdt RF. Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2. J Physiol 403: 91-104, 1988.
45. Schröder A, Newgreen D, Andersson KE. Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and EP1 receptor knockout mice. J Urol 172: 1166-1170, 2004.
46. Schüssler B. Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. A urodynamic study. Urol Res 18: 349-352, 1990.
47. Spicuzza L, Giembycz MA, Barnes PJ, Belvisi MG. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype. Br J Pharmacol 123: 1246-1252, 1998.
48. Steers W. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 4: S7-S18, 2002.
49. Su X, Ridel ES, Leon LA, Laping NJ. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension. Neurourol Urodyn 27: 249-253, 2008.
50. Su X, Leon LA, Laping NJ. Role of spinal Cav2.2 and Cav21 ion channels in bladder nociception. J Urol 179: 2464-2469, 2008.
51. 3 receptors in bladder afferent function. Am J Physiol Renal Physiol 295: F585-F594, 2008.
52. Takagi-Matsumoto H, Ng B, Tsukimi Y, Tajimi M. Effects of NSAIDs on bladder function in normal and cystitis rats: a comparison study of aspirin, indomethacin, and ketoprofen. J Pharmacol Sci 95: 458-465, 2004.
53. Testa R, Guarneri L, Angelico P, Velasco C, Poggesi E, Cilia A, Leonardi A. Effect of different 5-hydroxytryptamine receptor subtype antagonists on the micturition reflex in rats. BJU Int 87: 256-264, 2001.
54. Ueno A, Matsumoto H, Naraba H, Ikeda Y, Ushikubi F, Matsuoka T, Narumiya S, Sugimoto Y, Ichikawa A, Ohishi S. Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception. Biochem Pharmacol 62: 157-160, 2001.
55. Urade Y, Hayaishi O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 1482: 259-271, 2000.
56. Wright DH, Nantel F, Metters KM, Fort-Hutchinson AW. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur J Pharmacol 377: 101-115, 1999.
57. Zegar S, Tokar C, Enache LA, Rajagopol V, Zeller W, O'Connell M, Singh J, Muellner FW, Zembower DE. Development of a scalable process for DG-041, a potent EP3 receptor antagonist, via tandem Heck reactions. Org Process Res Dev 11: 747-753, 2007.